MedTrace Logo

Roflumilast In-Vitro Basophil Release

NCT00613587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2012-10-10

No results posted yet for this study

Summary

This study is looking for allergic asthmatics. Lung and allergy testing will be done to verify. If qualified, blood will be drawn for laboratory studies.

Conditions

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Creighton University

    lead OTHER

Principal Investigators

  • Robert G Townley, MD · Creighton University

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00613587 on ClinicalTrials.gov